Sunday, November 16, 2025
DIGESTWIRE
Contribute
CONTACT US
  • Home
  • World
  • UK
  • US
  • Breaking News
  • Technology
  • Entertainment
  • Health Care
  • Business
  • Sports
    • Sports
    • Cricket
    • Football
  • Defense
  • Crypto
    • Crypto News
    • Crypto Calculator
    • Coins Marketcap
    • Top Gainers and Loser of the day
    • Crypto Exchanges
  • Politics
  • Opinion
  • Blog
  • Founders
No Result
View All Result
  • Home
  • World
  • UK
  • US
  • Breaking News
  • Technology
  • Entertainment
  • Health Care
  • Business
  • Sports
    • Sports
    • Cricket
    • Football
  • Defense
  • Crypto
    • Crypto News
    • Crypto Calculator
    • Coins Marketcap
    • Top Gainers and Loser of the day
    • Crypto Exchanges
  • Politics
  • Opinion
  • Blog
  • Founders
No Result
View All Result
DIGESTWIRE
No Result
View All Result
Home Breaking News

Depression medication warning after death of Lady Gabriella Kingston’s husband

by DigestWire member
January 10, 2025
in Breaking News, UK News, World
0
Depression medication warning after death of Lady Gabriella Kingston’s husband
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

A coroner has warned about the effects of depression medication after the husband of the Prince and Princess Michael of Kent’s daughter took his own life.

Thomas Kingston, a 45-year-old financier, was found dead on 25 February last year at his parents’ home in the Cotswolds.

Katy Skerrett, senior coroner for Gloucestershire, has said action must be taken over the risk of suicide to patients after finding he was “suffering adverse effects of medication he had recently been prescribed”.

Mr Kingston married Lady Gabriella, 43, at Windsor Castle in 2019, with Queen Elizabeth II and the late Duke of Edinburgh among the guests.

The inquest into his death at Gloucestershire Coroner’s Court last year was told he had initially been given sertraline, a drug used to treat mental health problems, and zopiclone, a sleeping tablet, after complaining of trouble sleeping following stress at work.

But after they did not have the desired impact, a GP switched him from sertraline to citalopram. In the days leading up to his death, Mr Kingston stopped taking medication.

Read more:
Who was Thomas Kingston?

In a prevention of future deaths report, Ms Skerrett questioned whether there is adequate communication of the risks of suicide associated with such medication.

She also raised concerns about whether the current guidance to persist with selective serotonin reuptake inhibitor (SSRI) medications, or switch to an alternative SSRI medication, is appropriate when no benefit has been achieved – “especially when any adverse side effects are being experienced”.

The report was sent to the National Institute for Health and Care Excellence (NICE), the Medicines and Healthcare Products Regulatory Agency and the Royal College of General Practitioners, who have 56 days to respond.

The coroner’s concerns echo those of Mr Kingston’s wife, Lady Gabriella, who warned about the effects of the drugs during the inquest.

A statement by Lady Gabriella, read out by Ms Skerrett, said: “It seems highly likely to me that he had an adverse reaction to the pills that led him to take his life.”

“I believe anyone taking pills such as these need to be made more aware of the side effects to prevent any future deaths. If this could happen to Tom, this could happen to anyone,” she added.

Read more from Sky News:
Trump receives no-penalty sentence
Millions of users’ location data stolen
Nigel Farage ‘can’t be pushed or bullied’

Follow our channel and never miss an update.

Recording a narrative conclusion in December, Ms Skerrett said: “The evidence of his wife, family and business partner all supports his lack of suicidal intent. He was suffering adverse effects of medication he had recently been prescribed.”

Giving evidence to the inquest, Dr David Healy, a psychiatric medical expert, said Mr Kingston’s complaints that sertraline was continuing to make him anxious was a sign SSRIs “did not suit him” and he should not have been prescribed the same thing again.

Be the first to get Breaking News

Install the Sky News app for free

He said the guidelines and labels for SSRIs were not clear enough about going on the drugs in the first place or what the effect could be when moving from one to another.

A NICE spokesperson said: “We will consider the issues raised by the report and respond to the coroner directly.”

Anyone feeling emotionally distressed or suicidal can call Samaritans for help on 116 123 or email [email protected] in the UK. In the US, call the Samaritans branch in your area or 1 (800) 273-TALK

Read Entire Article
Tags: Breaking NewsSkynewsUK
Share30Tweet19
Next Post
South Africa Needs the Trump Treatment

South Africa Needs the Trump Treatment

California’s Climate Time for Choosing

California's Climate Time for Choosing

Did Someone Say Tight Money?

Did Someone Say Tight Money?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

No Result
View All Result
Coins MarketCap Live Updates Coins MarketCap Live Updates Coins MarketCap Live Updates
ADVERTISEMENT

Highlights

‘Summer House’ Cast Tease Season 10 Changes at BravoCon After Paige Exit

Chinese Tech Giant Alibaba Plans Stablecoin‑Like AI Payments With JPMorgan

Luann de Lesseps Addresses BravoCon 2025 Showdown With Erika Jayne

Woman, 20, dies while kayaking in River Tees

Fundstrat’s Tom Lee Disregards Crypto Market Weakness: Pain Is ‘Short Term’

Andre Russell released by Kolkata Knight Riders

Trending

Bavuma, Harmer and Jansen script sensational South Africa win at treacherous Eden Gardens
Cricket

Bavuma, Harmer and Jansen script sensational South Africa win at treacherous Eden Gardens

by DigestWire member
November 16, 2025
0

India roll over for 93 in their chase of 124 with their captain Shubman Gill absent with...

Pakistan opt to field, Asalanka out with illness

Pakistan opt to field, Asalanka out with illness

November 16, 2025
The Bavuma-Bosch ‘turning point’ in Harmer’s Test at Eden Gardens

The Bavuma-Bosch ‘turning point’ in Harmer’s Test at Eden Gardens

November 16, 2025
‘Summer House’ Cast Tease Season 10 Changes at BravoCon After Paige Exit

‘Summer House’ Cast Tease Season 10 Changes at BravoCon After Paige Exit

November 16, 2025
Chinese Tech Giant Alibaba Plans Stablecoin‑Like AI Payments With JPMorgan

Chinese Tech Giant Alibaba Plans Stablecoin‑Like AI Payments With JPMorgan

November 16, 2025
DIGEST WIRE

DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.

Privacy Policy     Terms and Conditions

Recent News

  • Bavuma, Harmer and Jansen script sensational South Africa win at treacherous Eden Gardens November 16, 2025
  • Pakistan opt to field, Asalanka out with illness November 16, 2025
  • The Bavuma-Bosch ‘turning point’ in Harmer’s Test at Eden Gardens November 16, 2025

Categories

  • Blockchain
  • Blog
  • Breaking News
  • Business
  • Cricket
  • Crypto Market
  • Cryptocurrency
  • Defense
  • Entertainment
  • Football
  • Founders
  • Health Care
  • Opinion
  • Politics
  • Sports
  • Strange
  • Technology
  • UK News
  • Uncategorized
  • US News
  • World

© 2020-23 Digest Wire. All rights belong to their respective owners.

No Result
View All Result
  • Home
  • World
  • UK
  • US
  • Breaking News
  • Technology
  • Entertainment
  • Health Care
  • Business
  • Sports
    • Sports
    • Cricket
    • Football
  • Defense
  • Crypto
    • Crypto News
    • Crypto Calculator
    • Blockchain
    • Coins Marketcap
    • Top Gainers and Loser of the day
    • Crypto Exchanges
  • Politics
  • Opinion
  • Strange
  • Blog
  • Founders
  • Contribute!

© 2024 Digest Wire - All right reserved.

Privacy Policy   Terms and Conditions

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.